Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies

被引：0

作者：

Nissen, Francis ^{[1
]}

Humbert, Marc ^{[2
,3
,4
]}

Gibson, Peter ^{[5
]}

Kostikas, Konstantinos ^{[6
]}

Jaumont, Xavier ^{[1
]}

Tassinari, Paolo ^{[1
]}

Pfister, Pascal ^{[1
]}

Bousquet, Jean ^{[7
,8
]}

机构：

[1] Novartis Pharma AG, Basel, Switzerland

[2] Univ Paris Sud, Paris, France

[3] Hop Kremlin Bicetre, Serv Pneumol, Paris, France

[4] INSERM, UMR S999, Paris, France

[5] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW, Australia

[6] Univ Ioannina, Sch Med, Dept Resp Med, Ioannina, Greece

[7] INSERM, U1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France

[8] Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France

来源：

关键词：

Asthma; -; management; Severe asthma; Exacerbation;

D O I：

10.1183/13993003.congress-2019.PA2549

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2549

引用

页数：3